[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355137-105":59,"doc-detail-355137-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-bioinformatics-and-experimental-analysis-of-cd276-for-prognosis-and-immune-infiltrates-in-colon-adenocarcinoma","The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon Adenocarcinoma","","Background: Colon adenocarcinoma (COAD) remains the third-most common gastrointestinal tumor yet lacks specific biomarkers for early diagnosis, treatment, and prognosis. Aims: This study evaluated CD276’s roles in tumorigenesis, prognosis, and immune processes in COAD. Methods and Results: CD276 expression was assessed using TCGA RNA-sequencing data, followed by Metascape and GSEA pathway analyses, and immune infiltration assessment via TIMER, with clinicopathologic correlation. High CD276 predicted microsatellite instability, survival outcomes, disease progression, and immune checkpoint-related features. Conclusions: Increased CD276 may drive COAD development through pro-tumor signaling and immune microenvironment remodeling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-bioinformatics-and-experimental-analysis-of-cd276-for-prognosis-and-immune-infiltrates-in-colon-adenocarcinoma/355137/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-bioinformatics-and-experimental-analysis-of-cd276-for-prognosis-and-immune-infiltrates-in-colon-adenocarcinoma/355137.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this study on CD276 in colon adenocarcinoma?","Question",{"text":112,"@type":113},"To evaluate CD276’s involvement in tumorigenesis, prognosis, and immune-related mechanisms in colon adenocarcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CD276 expression measured in colon adenocarcinoma?",{"text":117,"@type":113},"CD276 expression was established using RNA-sequencing transcriptomic data from The Cancer Genome Atlas (TCGA).",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical and immune findings were associated with high CD276 levels?",{"text":121,"@type":113},"High CD276 correlated with microsatellite instability status, survival and disease progression, and significant associations with immune cell infiltration and immune checkpoint expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355137,1790257496,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nThe Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltratesin Colon Adenocarcinoma  \nRui Chen1  | Tao Zhang1  | Jingru Yang1  | Longxia Zhang1  | Fei Su1,2   \n1Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, China | 2School of Basic Medical Sciences, Lanzhou University, Lanzhou, China  \nCorrespondence: Fei Su ([sufei19881216@163.com](sufei19881216@163.com))  \nReceived: 31 May 2025 | Revised: 20 January 2026 | Accepted: 3 February 2026  \nKeywords: CD276 | clinical outcome | colon adenocarcinoma | immune infiltration | prognosis  \nABSTRACT  \nBackground: Colon adenocarcinoma (COAD), although the third-most common type of gastrointestinal tumors, still lacks specific biomarkers for early diagnosis, treatment, and prognosis.  \nAims: This study aimed to evaluate the CD276 in tumorigenesis, prognosis and immunity for colon adenocarcinoma.  \nMethods and Results: The CD276 expression in colon adenocarcinoma was established by using RNA-sequencing transcriptomic data of The Cancer Genome Atlas (TCGA) databases. The biological functions of CD276 were evaluated using the Metascape database and Gene Set Enrichment Analysis (GSEA) . The association between CD276 and immune cell infiltration was investigated by TIMER website. Correlation analysis was performed between CD276 expression and clinicopathological characteristics. CD276 expression was significantly elevated in colon adenocarcinoma tumor (p \u003C 0.0001) . High CD276 was associated with microsatellite instability (MSI) status, patients' survival, and disease progression. Cox regression analysis revealed that CD276 was a risk factor for overall survival [hazard ratio (HR): 1.848, p = 2.64E−03], disease-specific survival (HR: 2.406, p = 5.35E−04), and progression-free interval (HR: 1.772, p = 2.04E−03). Moreover, CD276 level was significantly associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression.  \nConclusions: Our analyses indicated that increased CD276 may contribute to colon adenocarcinoma development by activating tumor-promoting signal pathways and altering the immune microenvironment.  \n1 | Introduction  \nRecent advances in cancer immunotherapy have revolutionized the treatment of advanced cancers, in particular, antibodies targeting programmed cell death 1 (PD-1), programmed cell  \ndeath ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) have produced durable remissions in various human solid tumors [1, 2] . Unfortunately, the remarkable therapeutic benefit of anti-PD-1/PD-L1 treatment are only achieved in a minor of patients including high PD-L1 expression  \n\n| Abbreviations: B7-H3, B7 homolog 3; CAFs, cancer-associated fibroblasts; COAD, colon adenocarcinoma; CTLA-4, cytotoxic T-lymphocyte-associated protein 4; DEGs, differentially expressed genes; DSS, disease-specific survival; EMT, epithelial–mesenchymal transition; FDR, false discovery rate; FPKM, fragments per kilobase per million; GACs, gastric adenocarcinomas; GSEA, Gene Set Enrichment Analysis; HGF, hepatocyte growth factor; HRs, hazard ratios; ICI, immune checkpoint inhibitors; IHC, immunohistochemistry; K-M, Kaplan–Meier; MSI, microsatellite instability; NES, normalized enrichment score; OS, overall survival; PD-1, programmed cell death protein 1; PD-L1, programmed death ligand 1; PFI, progress-free interval; ROC, receiver operating characteristic; TCGA, The Cancer Genome Atlas; TTs, tumor tissues.\u003Cbr>Rui Chen and Tao Zhang are considered co-first authors. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Cancer Reports published by Wiley Periodicals LLC. |\n\nCancer Reports, 2026; 9:e70503 1 of 18  \n[https://doi.org/10.1002/cnr2.70503](https://doi.org","cbCaip8FhwbxB4O5","https://ap.wps.com/l/cbCaip8FhwbxB4O5","pdf",7489209,18,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Data Processing","[{\"question\":\"What was the main goal of this study on CD276 in colon adenocarcinoma?\",\"answer\":\"To evaluate CD276’s involvement in tumorigenesis, prognosis, and immune-related mechanisms in colon adenocarcinoma.\"},{\"question\":\"How was CD276 expression measured in colon adenocarcinoma?\",\"answer\":\"CD276 expression was established using RNA-sequencing transcriptomic data from The Cancer Genome Atlas (TCGA).\"},{\"question\":\"What clinical and immune findings were associated with high CD276 levels?\",\"answer\":\"High CD276 correlated with microsatellite instability status, survival and disease progression, and significant associations with immune cell infiltration and immune checkpoint expression.\"}]","The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon Adenocarcinoma | PDF",1790116278,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c18f26ebc20e9cf84ed21212d7df9473.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55b2b6475678bbaf455f711d4015b80b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edbe78858dd019864b5aa8d0b5e1060c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad87ee296d4dc2a7eadc25fd4b1188dc.webp",980,1287]